SCHEMBL29605058

SCHEMBL29605058

Cn1c(S)nnc1C1(c2cccc(Br)c2)CC(F)(F)C1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.34
▸ BACE1 P56817 2/20 0.33
▸ CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22832649 0.88 CTSD (0.35) HSD11B1BACE1CTSD
SCHEMBL30520964 0.87 HSD11B1 (0.38) HSD11B1BACE1CTSD
SCHEMBL29606090 0.85 BACE1 (0.32) BACE1CTSD
SCHEMBL30374023 0.85 HSD11B1 (0.32) HSD11B1BACE1CTSD
SCHEMBL30728152 0.85 HSD11B1 (0.44) HSD11B1BACE1CTSD
SCHEMBL25178762 0.85 HSD11B1 (0.32) HSD11B1BACE1CTSD
SCHEMBL29614312 0.85 HSD11B1 (0.41) HSD11B1BACE1CTSD
SCHEMBL25411577 0.85 HSD11B1 (0.44) HSD11B1BACE1CTSD
SCHEMBL31274980 0.84 CHRNA1 (0.32) BACE1CTSD
SCHEMBL25311812 0.84 HSD11B1 (0.35) HSD11B1BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114364670-B Substituted benzyl-triazole compound for Cbl-b inhibition and further application thereof 纽力克斯治疗公司 2025-06-13 — — CN disclosed
WO-2024255762-A1 CBL-B INHIBITOR 上海齐鲁制药研究中心有限公司 2024-12-19 — — WO disclosed
EP-3990117-A1 SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FURTHER USES THEREOF Nurix Therapeutics, Inc. (US) 2022-05-04 — — EP disclosed
CN-114364670-A Substituted benzyl-triazoles for Cbl-b inhibition and further uses thereof 纽力克斯治疗公司 2022-04-15 — — CN disclosed
Send feedback